# Crisaborole Ointment for Skin Toxicity Induced by Cetuximab

> **NCT06118047** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 33 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer
- Cetuximab
- Skin Toxicity

## Interventions

- **DRUG:** Crisaborole Ointment
- **DRUG:** Cetuximab

## Key facts

- **NCT ID:** NCT06118047
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06118047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06118047, "Crisaborole Ointment for Skin Toxicity Induced by Cetuximab". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06118047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*